Assessment for Renovascular Hypertension
- Patients presenting two or more of the clinical clues listed below, suggesting renovascular hypertension, should be investigated (Grade D).
- Sudden onset or worsening of hypertension and age greater than 55 or less than 30 years;
- Presence of an abdominal bruit;
- Hypertension resistant to three or more drugs;
- Increase in serum creatinine level of ≥30% associated with use of an angiotensin-converting enzyme inhibitor or angiotensin II receptor antagonist;
- Other atherosclerotic vascular disease, particularly in patients who smoke or have dyslipidemia;
- Recurrent pulmonary edema associated with hypertensive surges.
- When available, the following tests are recommended to aid in the usual screening for renal vascular disease: captopril-enhanced radioisotope renal scan, Doppler sonography, magnetic resonance angiography and CT- angiography (for those with normal renal function) (Grade B). Captopril-enhanced radioisotope renal scan is not recommended for those with CKD (GFR <60 mL/min/1.73 m2) (Grade D).
- Patients with hypertension and presenting with at least one of the following clinical clues should be investigated for fibromuscular dysplasia (FMD)- related renal artery stenosis (Grade D: new guideline):
- Age less than 30 years, especially in non-obese women;
- Hypertension resistant to three or more drugs;
- Significant (>1.5 cm), unexplained asymmetry in kidney size;
- Abdominal bruit without apparent atherosclerosis;
- FMD in another vascular territory;
- Positive family history for FMD.
- In patients with confirmed renal FMD (Grade D; new guideline):
- Screening for cervicocephalic lesions and intracranial aneurysm is recommended;
- Screening for FMD in other vascular beds in the presence of suggestive symptoms is recommended.
- The following tests are recommended to screen for renal FMD (both with similar sensitivity and specificity) (Grade D; new guideline): magnetic resonance angiography and computed tomography angiography.